Rong Fan
About Rong Fan
Rong Fan is the Harold Hodgkinson Professor of Biomedical Engineering at Yale University, specializing in bioMEMS and advanced techniques in single-cell and spatial omics. He has a background in chemistry and has held various academic and entrepreneurial roles, contributing significantly to the fields of translational medicine and immuno-oncology.
Current Position at Yale University
Rong Fan currently holds the position of Harold Hodgkinson Professor of Biomedical Engineering at Yale University. He has been in this role since 2022. In addition to his professorship, he is also a Professor of Pathology at Yale University School of Medicine, a position he has held since 2021. His work at Yale focuses on advancing the field of biomedical engineering through research and education.
Previous Roles at Yale University
Rong Fan has a significant history with Yale University, having served as an Assistant Professor of Biomedical Engineering from 2010 to 2014 and as an Associate Professor from 2014 to 2020. During these years, he contributed to various research initiatives and educational programs, enhancing the university's reputation in biomedical engineering.
Education and Expertise
Rong Fan earned his Bachelor of Science degree in Chemistry from the University of Science and Technology of China. He then pursued further studies at the University of California, Berkeley, where he obtained his PhD in Chemistry. His expertise encompasses bioMEMS, single-cell omics, spatial omics, and translational medicine, with a focus on developing innovative solutions in biomedical research.
Involvement in Startups
Rong Fan is actively involved in several biotechnology startups. He co-founded IsoPlexis in 2014 and has served as a Co-Founder and SAB member at Singleron Biotechnologies since 2018. Additionally, he founded AtlasXomics Inc. in 2020. These roles reflect his commitment to translating scientific research into practical applications in the medical field.
Research Focus Areas
Rong Fan's research interests include autoimmunity, cell-based therapeutics, immune profiling, and immuno-oncology. He aims to develop treatments for autoimmune diseases and therapies that utilize living cells. His work in these areas is crucial for advancing understanding and treatment options in precision medicine and cancer therapy.